HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Varicella in pediatric renal transplant recipients.

Abstract
As of November 1991, 8 of 83 children who had received renal transplants at Massachusetts General Hospital since January 1979 required admission for primary varicella. All 8 had cutaneous manifestations of disease, and 4 had evidence of visceral disease. Three of these 8 children received varicella zoster immune globulin (VZIG) after exposure to varicella; in the remaining children, exposure was not revealed until symptoms were present. All 8 children were treated with high-dose intravenous acyclovir. Two children died of complications of varicella infection, including 1 child who received VZIG on the day of exposure to varicella. Neither VZIG prophylaxis nor treatment with intravenous acyclovir offers complete protection against severe varicella infection to immunosuppressed children who have received organ transplants. A high priority should be given to the evaluation of alternative treatments, such as vaccination to the varicella virus, which could be administered to susceptible transplant candidates, preferably prior to transplantation.
AuthorsR Lynfield, J T Herrin, R H Rubin
JournalPediatrics (Pediatrics) Vol. 90 Issue 2 Pt 1 Pg. 216-20 (Aug 1992) ISSN: 0031-4005 [Print] United States
PMID1322522 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immune Sera
  • varicella-zoster immune globulin
  • Acyclovir
Topics
  • Acyclovir (therapeutic use)
  • Adolescent
  • Chickenpox (drug therapy, therapy)
  • Child
  • Female
  • Herpesvirus 3, Human (immunology)
  • Humans
  • Immune Sera (administration & dosage)
  • Immunization, Passive
  • Kidney Transplantation
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: